AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
IN FAVOR OF COUMADIN OVER GENERIC WARFARIN
Authors: BENSON SR VANCEBRYAN K
Citation: Sr. Benson et K. Vancebryan, IN FAVOR OF COUMADIN OVER GENERIC WARFARIN, American journal of health-system pharmacy, 55(7), 1998, pp. 727-729
DIFFERENCES IN WARFARIN PRODUCTS ARE NOT THE ISSUE
Authors: BENSON SR VANCEBRYAN K
Citation: Sr. Benson et K. Vancebryan, DIFFERENCES IN WARFARIN PRODUCTS ARE NOT THE ISSUE, American journal of health-system pharmacy, 55(18), 1998, pp. 1935-1935
LORAZEPAM STABILITY IN PARENTERAL SOLUTIONS FOR CONTINUOUS INTRAVENOUS ADMINISTRATION
Authors: HOEY LL VANCEBRYAN K CLARENS DM WRIGHT DH KONSTANTINIDES FN GUAY DRP
Citation: Ll. Hoey et al., LORAZEPAM STABILITY IN PARENTERAL SOLUTIONS FOR CONTINUOUS INTRAVENOUS ADMINISTRATION, The Annals of pharmacotherapy, 30(4), 1996, pp. 343-346
THE IMPACT OF PRACTICE GUIDELINES ON PRESCRIBING PATTERNS OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS
Authors: TSCHIDA SJ HOEY LL VANCEBRYAN K
Citation: Sj. Tschida et al., THE IMPACT OF PRACTICE GUIDELINES ON PRESCRIBING PATTERNS OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS, Pharmacotherapy, 16(5), 1996, pp. 899-904
QT(C)-INTERVAL PROLONGATION ASSOCIATED WITH SLOW INTRAVENOUS ERYTHROMYCIN LACTOBIONATE INFUSIONS IN CRITICALLY ILL PATIENTS - A PROSPECTIVEEVALUATION AND REVIEW OF THE LITERATURE
Authors: TSCHIDA SJ GUAY DRP STRAKA RJ HOEY LL JOHANNING R VANCEBRYAN K
Citation: Sj. Tschida et al., QT(C)-INTERVAL PROLONGATION ASSOCIATED WITH SLOW INTRAVENOUS ERYTHROMYCIN LACTOBIONATE INFUSIONS IN CRITICALLY ILL PATIENTS - A PROSPECTIVEEVALUATION AND REVIEW OF THE LITERATURE, Pharmacotherapy, 16(4), 1996, pp. 663-674
RESISTANCE TO NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS
Authors: TSCHIDA SJ GRAUPE KJ HOEY LL VANCEBRYAN K
Citation: Sj. Tschida et al., RESISTANCE TO NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS, Pharmacotherapy, 16(3), 1996, pp. 409-418
COST-EFFECTIVE TREATMENT OF ATRACURIUM RESISTANCE IN CRITICALLY ILL PATIENTS
Authors: TSCHIDA SJ HOEY LL VANCEBRYAN K
Citation: Sj. Tschida et al., COST-EFFECTIVE TREATMENT OF ATRACURIUM RESISTANCE IN CRITICALLY ILL PATIENTS, American journal of health-system pharmacy, 52(16), 1995, pp. 1818-1819
A RETROSPECTIVE STUDY OF SODIUM-NITROPRUSSIDE USE AND ASSESSMENT OF THE POTENTIAL RISK OF CYANIDE POISONING
Authors: JOHANNING RJ ZASKE DE TSCHIDA SJ JOHNSON SV HOEY LL VANCEBRYAN K
Citation: Rj. Johanning et al., A RETROSPECTIVE STUDY OF SODIUM-NITROPRUSSIDE USE AND ASSESSMENT OF THE POTENTIAL RISK OF CYANIDE POISONING, Pharmacotherapy, 15(6), 1995, pp. 773-777
INAPPROPRIATE VANCOMYCIN PRESCRIBING BASED ON CRITERIA FROM THE CENTERS-FOR-DISEASE-CONTROL AND PREVENTION
Authors: JOHNSON SV HOEY LL VANCEBRYAN K
Citation: Sv. Johnson et al., INAPPROPRIATE VANCOMYCIN PRESCRIBING BASED ON CRITERIA FROM THE CENTERS-FOR-DISEASE-CONTROL AND PREVENTION, Pharmacotherapy, 15(5), 1995, pp. 579-585
ATRACURIUM RESISTANCE IN A CRITICALLY ILL PATIENT
Authors: TSCHIDA SJ HOEY LL NAHUM A VANCEBRYAN K
Citation: Sj. Tschida et al., ATRACURIUM RESISTANCE IN A CRITICALLY ILL PATIENT, Pharmacotherapy, 15(4), 1995, pp. 533-539
INCONSISTENCY WITH TRAIN-OF-4 MONITORING IN A CRITICALLY ILL PARALYZED PATIENT
Authors: TSCHIDA SJ HOEY LL VANCEBRYAN K
Citation: Sj. Tschida et al., INCONSISTENCY WITH TRAIN-OF-4 MONITORING IN A CRITICALLY ILL PARALYZED PATIENT, Pharmacotherapy, 15(4), 1995, pp. 540-545
TRAIN-OF-4 - TO USE OR NOT TO USE
Authors: TSCHIDA SJ HOEY LL MATHER D VANCEBRYAN K
Citation: Sj. Tschida et al., TRAIN-OF-4 - TO USE OR NOT TO USE, Pharmacotherapy, 15(4), 1995, pp. 546-550
PROLONGED NEUROMUSCULAR BLOCKADE IN 2 CRITICALLY ILL PATIENTS TREATEDWITH ATRACURIUM
Authors: HOEY LL JOSLIN SM NAHUM A VANCEBRYAN K
Citation: Ll. Hoey et al., PROLONGED NEUROMUSCULAR BLOCKADE IN 2 CRITICALLY ILL PATIENTS TREATEDWITH ATRACURIUM, Pharmacotherapy, 15(2), 1995, pp. 254-259
CONTINUOUS INTRAVENOUS INFUSIONS OF LORAZEPAM VERSUS MIDAZOLAM FOR SEDATION
Authors: SOLBERG CL VANCEBRYAN K HOEY LL
Citation: Cl. Solberg et al., CONTINUOUS INTRAVENOUS INFUSIONS OF LORAZEPAM VERSUS MIDAZOLAM FOR SEDATION, Critical care medicine, 23(8), 1995, pp. 1448-1449
ANTIINFECTIVE AGENTS AND HEPATIC-DISEASE
Authors: TSCHIDA SJ VANCEBRYAN K ZASKE DE
Citation: Sj. Tschida et al., ANTIINFECTIVE AGENTS AND HEPATIC-DISEASE, The Medical clinics of North America, 79(4), 1995, pp. 895-917
ALCOHOL-WITHDRAWAL - WHAT IS THE BENZODIAZEPINE OF CHOICE - COMMENT
Authors: HOEY L JOSLIN S VANCEBRYAN K
Citation: L. Hoey et al., ALCOHOL-WITHDRAWAL - WHAT IS THE BENZODIAZEPINE OF CHOICE - COMMENT, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 972-972
A COMPARATIVE-ASSESSMENT OF VANCOMYCIN-ASSOCIATED NEPHROTOXICITY IN THE YOUNG VERSUS THE ELDERLY HOSPITALIZED PATIENT
Authors: VANCEBRYAN K ROTSCHAFER JC GILLILAND SS RODVOLD KA FITZGERALD CM GUAY DRP
Citation: K. Vancebryan et al., A COMPARATIVE-ASSESSMENT OF VANCOMYCIN-ASSOCIATED NEPHROTOXICITY IN THE YOUNG VERSUS THE ELDERLY HOSPITALIZED PATIENT, Journal of antimicrobial chemotherapy, 33(4), 1994, pp. 811-821
A RETROSPECTIVE REVIEW AND ASSESSMENT OF BENZODIAZEPINES IN THE TREATMENT OF ALCOHOL-WITHDRAWAL IN HOSPITALIZED-PATIENTS
Authors: HOEY LL MAJI A VANCEBRYAN K
Citation: Ll. Hoey et al., A RETROSPECTIVE REVIEW AND ASSESSMENT OF BENZODIAZEPINES IN THE TREATMENT OF ALCOHOL-WITHDRAWAL IN HOSPITALIZED-PATIENTS, Pharmacotherapy, 14(5), 1994, pp. 572-578
A PROSPECTIVE EVALUATION OF BENZODIAZEPINE GUIDELINES IN THE MANAGEMENT OF PATIENTS HOSPITALIZED FOR ALCOHOL-WITHDRAWAL
Authors: HOEY LL NAHUM A VANCEBRYAN K
Citation: Ll. Hoey et al., A PROSPECTIVE EVALUATION OF BENZODIAZEPINE GUIDELINES IN THE MANAGEMENT OF PATIENTS HOSPITALIZED FOR ALCOHOL-WITHDRAWAL, Pharmacotherapy, 14(5), 1994, pp. 579-585
BAYESIAN FORECASTING OF SERUM VANCOMYCIN CONCENTRATIONS WITH NON-STEADY-STATE SAMPLING STRATEGIES
Authors: RODVOLD KA ROTSCHAFER JC GILLILAND SS GUAY DRP VANCEBRYAN K
Citation: Ka. Rodvold et al., BAYESIAN FORECASTING OF SERUM VANCOMYCIN CONCENTRATIONS WITH NON-STEADY-STATE SAMPLING STRATEGIES, Therapeutic drug monitoring, 16(1), 1994, pp. 37-41
ALTERNATIVE VIEWS ON THE EFFECTS OF RECOMBINANT INTERLEUKIN-1-RECEPTOR ANTAGONIST
Authors: VANCEBRYAN K HOEY LL JOSLIN SM
Citation: K. Vancebryan et al., ALTERNATIVE VIEWS ON THE EFFECTS OF RECOMBINANT INTERLEUKIN-1-RECEPTOR ANTAGONIST, American journal of hospital pharmacy, 51(21), 1994, pp. 2724-2725
STORAGE OF LORAZEPAM IN POLYVINYL-CHLORIDE BAGS
Authors: HOEY LL GUAY DRP VANCEBRYAN K
Citation: Ll. Hoey et al., STORAGE OF LORAZEPAM IN POLYVINYL-CHLORIDE BAGS, American journal of hospital pharmacy, 51(14), 1994, pp. 1825-1826
RESPONSE TO PANCURONIUM AFTER LOSS OF ATRACURIUM-INDUCED NEUROMUSCULAR BLOCKADE
Authors: KELLY KJ CLARENS DM KOHLS PR NAHUM A VANCEBRYAN K
Citation: Kj. Kelly et al., RESPONSE TO PANCURONIUM AFTER LOSS OF ATRACURIUM-INDUCED NEUROMUSCULAR BLOCKADE, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 862-865
A RETROSPECTIVE ANALYSIS OF LONG-TERM USE OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS IN THE INTENSIVE-CARE UNIT, AND GUIDELINES FOR DRUG SELECTION
Authors: CLARENS DM KELLY KJ GILLILAND SS KOHLS PK NAHUM A VANCEBRYAN K
Citation: Dm. Clarens et al., A RETROSPECTIVE ANALYSIS OF LONG-TERM USE OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS IN THE INTENSIVE-CARE UNIT, AND GUIDELINES FOR DRUG SELECTION, Pharmacotherapy, 13(6), 1993, pp. 647-655
COMPARISON OF VANCOMYCIN PHARMACOKINETICS IN HOSPITALIZED ELDERLY ANDYOUNG-PATIENTS USING A BAYESIAN FORECASTER
Authors: GUAY DRP VANCEBRYAN K GILLILAND S RODVOLD K ROTSCHAFER J
Citation: Drp. Guay et al., COMPARISON OF VANCOMYCIN PHARMACOKINETICS IN HOSPITALIZED ELDERLY ANDYOUNG-PATIENTS USING A BAYESIAN FORECASTER, Journal of clinical pharmacology, 33(10), 1993, pp. 918-922
Risultati: 1-25 | 26-27